Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19796695 | 0.92 | TSHR (0.32) | TSHR | |
| SCHEMBL19796600 | 0.91 | TSHR (0.37) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19796583 | 0.91 | TSHR (0.37) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19796517 | 0.90 | TSHR (0.38) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL21615468 | 0.89 | TSHR (0.31) | TSHR | |
| SCHEMBL19797001 | 0.89 | TSHR (0.35) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19796586 | 0.88 | TSHR (0.35) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19796829 | 0.87 | FFAR4 (0.34) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL19796542 | 0.87 | TSHR (0.36) | TSHRCYP2C9ALDH1A1LMNAMAPT | |
| SCHEMBL18646445 | 0.86 | TSHR (0.31) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | DIC CORPORATION (JP) | 2023-08-29 | — | — | US | disclosed |
| US-20200399539-A1 | POLYMERIZABLE COMPOUND AS WELL AS LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE EACH INCLUDING POLYMERIZABLE COMPOUND | DIC CORPORATION (JP) | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739270-B2 | Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound | OCIAD2, PKN2, SKP1 | TSHR 4737/4885CYP2C9 3955/4885ALDH1A1 3448/4885 |
| US-20200399539-A1 | POLYMERIZABLE COMPOUND AS WELL AS LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE EACH INCLUDING POLYMERIZABLE COMPOUND | OCIAD2, PKN2, SKP1 | TSHR 4737/4885CYP2C9 3955/4885ALDH1A1 3448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.